556TiP A phase I study of SGN-STNV, a novel antibody–drug conjugate targeting sialyl-thomsen-nouveau antigen (STn), in adults with advanced solid tumors (SGNSTNV-001)

Autor: Lakhani, N.J., Braña, I., Chiu, V.K., Dowlati, A., Lee, E.K., McGoldrick, S.M., Minchom, A., Tian, X., Patnaik, A.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S613-S614
Databáze: ScienceDirect